SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories - Quaterly Results

03 Aug 2023 Evaluate
A decent increase of about 64.12% in the turnover to Rs. 3629.94 millions was observed for the quarter ended June 2023. The turnover stood at Rs. 2211.70 millions during the similar quarter previous year.Net Profit witnessed a 532.29% growth almost the double from Rs. 98.41 millions to Rs. 622.24  millions  of same quarter last year.Operating Profit saw a handsome growth to 993.04 millions from 289.90 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 3629.94 2211.70 64.12 3629.94 2211.70 64.12 11911.98 9510.77 25.25
Other Income 20.39 5.12 298.24 20.39 5.12 298.24 97.48 20.77 369.33
PBIDT 993.04 289.90 242.55 993.04 289.90 242.55 2810.56 1442.71 94.81
Interest 22.14 28.58 -22.53 22.14 28.58 -22.53 130.67 134.94 -3.16
PBDT 970.90 261.32 271.54 970.90 261.32 271.54 2679.89 1307.77 104.92
Depreciation 135.86 127.98 6.16 135.86 127.98 6.16 527.76 490.36 7.63
PBT 835.04 133.34 526.25 835.04 133.34 526.25 2152.13 817.41 163.29
TAX 212.80 34.93 509.22 212.80 34.93 509.22 520.94 182.06 186.14
Deferred Tax 3.33 -6.07 -154.86 3.33 -6.07 -154.86 17.04 -22.16 -176.90
PAT 622.24 98.41 532.29 622.24 98.41 532.29 1631.19 635.35 156.74
Equity 129.01 129.00 0.01 129.01 129.00 0.01 129.01 129.01 0.00
PBIDTM(%) 27.36 13.11 108.71 27.36 13.11 108.71 23.59 15.17 55.54

Neuland Laboratories Share Price

14408.95 -539.25 (-3.61%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×